The increased mitochondrial ROS in RSL3 treated group demonstrated that low concentration RSL3 had a potential effect on mitochondrial GPX4 activity and inhibited the enzyme catalyzing hyperoxide, which made cancer cells vulnerable to subsequent oxidative stress [34, 35]. This evidence concerns the gene GPX4 and cancer.